Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan P Vandenbroucke

Showing results (1-10 of 158) with videos related to

Pageof 16
Sort By:
BMJ (Clinical Research Ed.)|September 27, 2003
Balancing benefits and harms in health care: observational data on harm should complement systematic reviews of benefitJan P Vandenbroucke
Journal of Clinical Epidemiology|January 28, 2003
Alvan Feinstein and the art of consulting: how to define a research questionJan P Vandenbroucke
Sozial- Und Praventivmedizin|September 16, 2003
Continuing controversies over "risks and rates"--more than a century after William Farr's "On prognosis"Jan P Vandenbroucke
Lancet (London, England)|May 26, 2004
When are observational studies as credible as randomised trials?Jan P Vandenbroucke
Journal of the Royal Society of Medicine|March 14, 2013
Adolphe Vorderman's 1897 study on beriberi: an example of scrupulous efforts to avoid biasJan P Vandenbroucke
Journal of Clinical Epidemiology|February 3, 2009
STREGA, STROBE, STARD, SQUIRE, MOOSE, PRISMA, GNOSIS, TREND, ORION, COREQ, QUOROM, REMARK... and CONSORT: for whom does the guideline toll?Jan P Vandenbroucke
Nederlands Tijdschrift Voor Geneeskunde|February 10, 2009
[Limitations of observation]Jan P Vandenbroucke
Lancet (London, England)|April 14, 2009
The HRT controversy: observational studies and RCTs fall in lineJan P Vandenbroucke
International Journal of Epidemiology|October 26, 2013
Commentary: Snow's paper on 'offensive trades'--with the benefit of 150 years of hindsightJan P Vandenbroucke
International Journal of Epidemiology|May 29, 2004
Commentary: the HRT story: vindication of old epidemiological theoryJan P Vandenbroucke
Pageof 16

Showing results (1-10 of 158) with videos related to

Sort By:
Pageof 16
BMJ (Clinical Research Ed.)|September 27, 2003
Balancing benefits and harms in health care: observational data on harm should complement systematic reviews of benefitJan P Vandenbroucke
Journal of Clinical Epidemiology|January 28, 2003
Alvan Feinstein and the art of consulting: how to define a research questionJan P Vandenbroucke
Sozial- Und Praventivmedizin|September 16, 2003
Continuing controversies over "risks and rates"--more than a century after William Farr's "On prognosis"Jan P Vandenbroucke
Lancet (London, England)|May 26, 2004
When are observational studies as credible as randomised trials?Jan P Vandenbroucke
Journal of the Royal Society of Medicine|March 14, 2013
Adolphe Vorderman's 1897 study on beriberi: an example of scrupulous efforts to avoid biasJan P Vandenbroucke
Journal of Clinical Epidemiology|February 3, 2009
STREGA, STROBE, STARD, SQUIRE, MOOSE, PRISMA, GNOSIS, TREND, ORION, COREQ, QUOROM, REMARK... and CONSORT: for whom does the guideline toll?Jan P Vandenbroucke
Nederlands Tijdschrift Voor Geneeskunde|February 10, 2009
[Limitations of observation]Jan P Vandenbroucke
Lancet (London, England)|April 14, 2009
The HRT controversy: observational studies and RCTs fall in lineJan P Vandenbroucke
International Journal of Epidemiology|October 26, 2013
Commentary: Snow's paper on 'offensive trades'--with the benefit of 150 years of hindsightJan P Vandenbroucke
International Journal of Epidemiology|May 29, 2004
Commentary: the HRT story: vindication of old epidemiological theoryJan P Vandenbroucke
Pageof 16